awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37930534-6E9FFC52-8306-4C68-8410-3603CBB1D850
Q37930534-6E9FFC52-8306-4C68-8410-3603CBB1D850
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37930534-6E9FFC52-8306-4C68-8410-3603CBB1D850
Scientific research at Fujian Academy of Integrative Medicine: current status and future directions.
P2860
Q37930534-6E9FFC52-8306-4C68-8410-3603CBB1D850
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37930534-6E9FFC52-8306-4C68-8410-3603CBB1D850
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a94fd6c27a8c110dad3ddb96cbaaae0ddf42cbee
P2860
SARM inhibits both TRIF- and MyD88-mediated AP-1 activation.